Effectiveness and Prognostic Factors of Everolimus in Patients with Pancreatic Neuroendocrine Neoplasms.

Intern Med · 2023 · PMC9908390 · PMID 35705270

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

For example, a phase III trial of somatostatin analogs in a similar patient population showed no benefit from these agents in terms of OS, despite a highly significant improvement in PFS (19-21).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.